Outcome of Patients with CML Treated with Dasatinib or Nilotinib after Failure of Second Prior TKIs.

被引：0

作者：

Rossi, Antonella Russo ^{[1
]}

Breccia, Massimo ^{[2
]}

Castagnetti, Fausto ^{[3
]}

Luciano, Luigiana ^{[4
]}

Gozzini, Antonella ^{[5
]}

Annunziata, Mario ^{[6
]}

Martino, Bruno ^{[7
]}

Stagno, Fabio ^{[8
]}

Cavazzini, Francesco ^{[9
]}

Tiribelli, Mario ^{[10
]}

Visani, Giuseppe ^{[11
]}

Pregno, Patrizia ^{[12
]}

Musto, Pellegrino ^{[13
]}

Fava, Carmen ^{[14
]}

Avanzini, Paolo ^{[15
]}

Turri, Diamante ^{[16
]}

Sgherza, Nicola ^{[1
]}

Albano, Francesco ^{[1
]}

Specchia, Giorgina ^{[1
]}

机构：

[1] Univ Bari, Bari, Italy

[2] Univ Rome, Rome, Italy

[3] Univ Bologna, Bologna, Italy

[4] Univ Naples Federico 2, Naples, Italy

[5] Careggi Univ Hosp, Dept Hematol, Florence, Italy

[6] Osped Antonio Cardarelli, Naples, Italy

[7] Osped Bianchi Melacrino Morelli, Reggio Di Calabria, Italy

[8] Univ Catania, Catania, Italy

[9] Univ Ferrara, I-44100 Ferrara, Italy

[10] Univ Udine, I-33100 Udine, Italy

[11] Osped Pesaro, Pesaro, Italy

[12] Univ Turin, Turin, Italy

[13] Ctr Riferimento Oncol Basilicata, Rionero In Vulture, Pz, Italy

[14] Osped Orbassano, Orbassano, TO, Italy

[15] Univ Reggio Emilia, Reggio Emilia, Italy

[16] Univ Palermo, Palermo, Italy

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：946 / 946

页数：1